language-icon Old Web
English
Sign In
Acemap > Paper > Superiority of CyBorD Over VAD is More Evident in First than in Second Line Treatment of Multiple Myeloma

Superiority of CyBorD Over VAD is More Evident in First than in Second Line Treatment of Multiple Myeloma

2019 
Keywords:
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []
    logo
    • CCF Conference Analysis
    • Map Galaxy
    • What's New
    © Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.